Results 1 to 10 of about 102 (102)
Актуальные проблемы теоретической и клинической медицины, 2022 This work reflects proton pump inhibitors, which today are among the most commonly prescribed drugs in gastroenterology around the world. Impact of PPIs on the severity of the clinical course of COVID-19 infection in patients.Objective: To determine the ...
A. K. Zhangabylov +2 more
doaj +1 more source
Effect of antisecretory treatment on gastrointestinal microbiota
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2018 Aim of review. To present the data on the effect of proton pump inhibitors to gastrointestinal microbiota. Summary. Proton pump inhibitors (PPI) - is a basic class of drugs for acid-related diseases treatment. The data proving gastrointestinal microbiota
D. Ye. Rumyantseva +3 more
doaj +1 more source
Safety of proton pump inhibitors
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2016 Aim of review. To present modern data on the possible mechanisms of development of side effects of the proton pump inhibitors (PPI). Summary. Proton pump inhibitors is the class of pharmaceuticals that block N+/K+-ATPase of gastric parietal cells.
Ye. A. Losik
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Concomitant administration of clopidogrel and proton pump inhibitors (PPI), the possible influence of PPI on the effectiveness of clopidogrel often raises questions among practitioners.
S. Yu. Martsevich, A. Yu. Suvorov
doaj +1 more source
Выбор ингибитора протонной помпы в условиях антитромбоцитарной терапии у коморбидного пациента
Медицинский совет, 2016 Под полиморбидностью понимают наличие нескольких патологических состояний у одного пациента. Известно, сочетание 2–5-болезней меняет классическую клиническую картину каждой патологии, чаще всего утяжеляет течение и увеличивает количество осложнений ...
doaj +1 more source
Eradication of Helicobacter Pylori
Медицинский совет, 2015 General idea. The article is a review of data on Helicobacter pylori resistance to antibiotics, the impact of CYP2C19 polymorphism on the metabolism of proton pump inhibitors, and recent findings on the effectiveness of eradication.
V. V. Tsukanov +3 more
doaj +1 more source
Pharmacogenetics of proton pump inhibitors
Медицинский совет, 2015 Proton pump inhibitors (PPI) are currently the most effective class of antisecretory drugs widely used in the treatment of non-ulcer dyspepsia, reflux esophagitis and GERD, peptic ulcer disease and H. pilory infection, as well as NSAID-associated gastric
M. V. Leonova
doaj +1 more source
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2018 The aim of publication. To present modern concept on etiology and pathogenesis of the peptic ulcer (PUD) to general practitioners, to acquaint them with modern diagnostic methods and main treatment approaches of this disease. Summary.
V. T. Ivashkin +8 more
doaj +1 more source
Pleiotropic effects of rabeprazole at acid-related diseases
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2018 Aim of investigation. To study association interleukin-1 (IL-1) gene (rs16944), interleukin-6 (IL-6) gene (rs1800795), interleukin-10 (IL-10) gene (rs1800896) polymorphisms with development of acute pancreatitis (AP) in the Russian population.
A. V. Zaborovsky +3 more
doaj +1 more source
Treatment compliance at initial and maintenance therapy at gastroesophageal reflux disease
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2018 Aim of investigation. To analyze treatment compliance at initial course and maintenance treatment by proton pump inhibitors at gastroesophageal reflux disease (GERD). Material and methods. Overall 84 GERD patients with took part in prospective study: 50 (
V. I. Simanenkov +2 more
doaj +1 more source